Add Yahoo as a preferred source to see more of our stories on Google. BURLINGTON — Researchers at the University of Vermont have developed a more precise way to assess stroke risk in people with ...
A recent British study published in European Heart Journal has reignited discussions on the role of sex as a determinant in prescribing anticoagulants, particularly for patients under the age of 65.
The improved CHA2DS2-VASc-Biomarkers risk calculator accounts for these additional risks factors by adding results from the blood tests to the calculation. In the first study, researchers looked at ...
A risk-assessment tool incorporating NT-proBNP and high-sensitivity troponin performs better than clinical scores for predicting stroke among patients with atrial fibrillation (AF) who are taking oral ...
BOSTON — A common stroke risk calculator can help electrophysiologists and cardiologists distinguish which patients with subclinical atrial fibrillation (SCAF) are most likely to benefit from ...
Biomarkers improve CHA2DS2-VASc model fit and predictive ability, with NTproBNP and GDF-15 yielding the best fit. (HealthDay News) — Biomarkers of ischemic stroke risk are positively associated with ...
BOSTON -- In deciding on anticoagulation with apixaban (Eliquis) for patients with device-detected, subclinical atrial fibrillation (SCAF), one key number appeared to distinguish those for whom the ...
Researchers at the University of Vermont have developed a more precise way to assess stroke risk in people with atrial fibrillation (A-Fib), a condition that affects 10.5 million Americans and is a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results